These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2966586)

  • 21. Estradiol and progesterone receptors in gynecologic sarcomas.
    Lantta M; Kärkkäinen J; Wahlström T; Widholm O
    Acta Obstet Gynecol Scand; 1984; 63(6):505-8. PubMed ID: 6507052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex steroid receptors in endometrial cancer.
    Chambers JT
    Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of estrogen receptor status on survival in patients with endometrial cancer.
    Martin JD; Hähnel R; McCartney AJ; Woodings TL
    Am J Obstet Gynecol; 1983 Oct; 147(3):322-4. PubMed ID: 6624797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial adenocarcinoma. A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors.
    Geisinger KR; Homesley HD; Morgan TM; Kute TE; Marshall RB
    Cancer; 1986 Oct; 58(7):1518-25. PubMed ID: 3742470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine aspects of human uterine sarcoma: a preliminary study.
    Tseng L; Tseng JK; Mann WJ; Chumas JC; Stone ML; Mazella J; Sun B; Amalfitano TG; Wallach RC
    Am J Obstet Gynecol; 1986 Jul; 155(1):95-101. PubMed ID: 2942037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormonal receptors in endometrial neoplasias.
    Contreras Ortiz O; Sananes CE
    Eur J Gynaecol Oncol; 1988; 9(5):396-8. PubMed ID: 2975993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse of endometrial carcinoma related to steroid receptor concentration, staging, histologic grading and myometrial invasion.
    Lindahl B; Alm P; Fernö M; Grundsell H; Norgren A; Tropé C
    Anticancer Res; 1986; 6(6):1317-20. PubMed ID: 3813487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An ultrastructural comparison of grade I and II endometrial adenocarcinoma considering estrogen and progesterone receptor status.
    Horbelt DV; Freedman RS; Roberts DK; Walker NJ; Edwards CL; Jones LA
    Gynecol Oncol; 1984 Jun; 18(2):150-6. PubMed ID: 6735260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estradiol and progesterone receptors in two cases of endometrial stromal sarcoma.
    Lantta M; Kahanpää K; Kärkkäinen J; Lehtovirta P; Wahlström T; Widholm O
    Gynecol Oncol; 1984 Jun; 18(2):233-9. PubMed ID: 6735266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endometrial adenocarcinoma as a model for hormone-dependency and hormone-responsiveness of gynaecological cancers.
    Bonte J
    Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):335-41. PubMed ID: 6526120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy?
    Benraad TJ; Friberg LG; Koenders AJ; Kullander S
    Acta Obstet Gynecol Scand; 1980; 59(2):155-9. PubMed ID: 7405552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estradiol and progesterone receptors in human breast cancer.
    Mureşan Z; Voiculetz N
    Neoplasma; 1985; 32(2):217-24. PubMed ID: 4000310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma.
    Lindahl B; Alm P; Borg A; Fernö M; Grundsell H; Johnsson JE; Norgren A; Tropé C
    Anticancer Res; 1982; 2(4):203-7. PubMed ID: 7149649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of protein expression in endometrial adenocarcinoma cells by in vitro exposure to estradiol and progesterone.
    O'Brien TJ; Hernandez W; Jernstrom PJ; Seymour DB; Morrow CP; Sykes JA
    Am J Obstet Gynecol; 1981 Jan; 139(1):67-72. PubMed ID: 7457524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium.
    Geisinger KR; Marshall RB; Kute TE; Homesley HD
    Cancer; 1986 Oct; 58(7):1506-17. PubMed ID: 3742469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
    Metzger DA; Lessey BA; Soper JT; McCarty KS; Haney AF
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):946-50. PubMed ID: 1833687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas.
    Soper JT; McCarty KS; Hinshaw W; Creasman WT; McCarty KS; Clarke-Pearson DL
    Am J Obstet Gynecol; 1984 Oct; 150(4):342-8. PubMed ID: 6486200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.